awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q21004071-37660772-3E49-4D50-89C0-16FF7FBC5E53
Q21004071-37660772-3E49-4D50-89C0-16FF7FBC5E53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21004071-37660772-3E49-4D50-89C0-16FF7FBC5E53
Treatment of Fabry disease: outcome of a comparative trial with agalsidase alfa or beta at a dose of 0.2 mg/kg
P2860
Q21004071-37660772-3E49-4D50-89C0-16FF7FBC5E53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21004071-37660772-3E49-4D50-89C0-16FF7FBC5E53
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
089c582fb6ea830f8fd4d32142d1ec87d6792b4f
P2860
Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey).